Intuitive Surgical, Inc. (ISRG)
Healthcare · Medical - Instruments & Supplies · Data as of 2026-10-22
Bottom line
ISRG is trading at a premium to its history, near its historical support zone, and recent volume suggests money flowing in. The picture is mixed, so it may be worth watching rather than acting on. Past patterns are not a guarantee of future results.
Valuation — Paying a lot for the growth (Red)
For a fast-growing company like ISRG (revenue is growing about 21% a year), we weigh next year's expected P/E of 41× against the 12% earnings growth analysts expect (a forward PEG of 3.41, 17 estimates). The market is paying a large premium for that growth to continue. Its current multiple sits around the 13th percentile of its own last five years — toward the low end of its own range.
Price zones — Near its historical support zone (Green)
At $443.85, the stock is close to the lower end of its recent range. Over the past year ISRG has traded between $328.57 and $603.88; its historical support zone sits near $436.91 and resistance near $603.88. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $328.57–$603.88 · 50-day average $395.04 · 200-day average $436.91
Money flow — Money is flowing in (Green)
Recent trading in ISRG shows more volume on rising days than falling days, a pattern often described as accumulation. Volume on up days has been about 2.0× volume on down days over the last 30 sessions.
Dividends & company facts
ISRG doesn't pay a dividend, but it bought back $1.9 billion of its shares in fiscal 2025, about 1.3% of its market value. Its share count fell 2.8% over the past year and 4.1% over five.
- Buybacks
- 1.26% (fiscal 2025)
- Shares, past year
- -2.8%
- Revenue, 12 months
- $11.6B
- Profit, 12 months
- $3.0B
- Employees
- 17,021
- CEO
- David J. Rosa
- Headquarters
- Sunnyvale, CA
- Listed since
- 2000 · NASDAQ
About the company
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets.
Related stocks
一句话结论
ISRG 相对自身历史处于溢价水平，接近其历史支撑区，近期成交量显示资金正在流入。整体情况好坏参半，也许更适合先观察，而不是急于行动。过去的形态并不能保证未来的结果。
估值 — 为这份增长付出的价格不低
对 ISRG 这样的高增长公司（营收年增长约 21%），我们把它明年的预期市盈率 41× 与分析师预计的 12% 盈利增速放在一起看（前瞻 PEG 为 3.41，来自 17 份预测）。市场为这份增长能够延续，付出了不小的溢价。它当前的估值倍数大约位于自身过去五年分布的第 13 百分位——处于自身区间的偏低位置。
价格区间 — 接近其历史支撑区
目前价格为 $443.85，接近其近期区间的下沿。过去一年 ISRG 的价格在 $328.57 到 $603.88 之间波动；其历史支撑区在 $436.91 附近，阻力区在 $603.88 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 资金正在流入
ISRG 近期上涨日的成交量高于下跌日，这种形态常被称为吸筹。过去 30 个交易日，上涨日的成交量约为下跌日的 2.0×。
股息与公司概况
ISRG 不派发股息，但在 2025 财年回购了 19.4亿美元 的股票，约占市值的 1.3%。其股数过去一年减少了 2.8%，五年减少了 4.1%。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.